Goldman Sachs MarketBeta Russell 1000 Value Eq ETF Vs. Travere Therapeutics, Inc. Industry Stock Comparison

Buy

71

GVUS
Goldman Sachs MarketBeta Russell 1000 Value Eq ETF

Last Price:

$54.58

Seasonality Move:

1.15%

Buy

80

TVTX
Travere Therapeutics, Inc.

Last Price:

$40.3200

Seasonality Move:

33.23%

Buy

71

Goldman Sachs MarketBeta Russell 1000 Value Eq ETF (GVUS) is a Buy

Is Goldman Sachs MarketBeta Russell 1000 Value Eq ETF a Buy, Sell or Hold?

The current Goldman Sachs MarketBeta Russell 1000 Value Eq ETF [GVUS] share price is $54.61. The Score for GVUS is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
GVUS is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

Buy

80

Travere Therapeutics, Inc. (TVTX) is a Buy

Is Travere Therapeutics, Inc. a Buy, Sell or Hold?

The current Travere Therapeutics, Inc. [TVTX] share price is $40.2800. The Score for TVTX is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
TVTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

GVUS Stock Price Chart

What is Goldman Sachs MarketBeta Russell 1000 Value Eq ETF's stock price today?

The Goldman Sachs MarketBeta Russell 1000 Value Eq ETF share price today is $54.61

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GVUS is experiencing slight buying pressure.

TVTX Stock Price Chart

What is Travere Therapeutics, Inc.'s stock price today?

The Travere Therapeutics, Inc. share price today is $40.2800

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TVTX is experiencing slight buying pressure.

GVUS Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	0.41	Buy
Relative Strength Index (14 RSI):	61.39	Buy
Chaikin Money Flow:	0	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(52.72 - 54.5)	Buy
Bollinger Bands (100):	(51.26 - 53.46)	Buy

TVTX Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	9.67	Buy
Relative Strength Index (14 RSI):	69.35	Buy
Chaikin Money Flow:	1508490	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(34.0318 - 36.4718)	Buy
Bollinger Bands (100):	(20.7309 - 34.2909)	Buy

GVUS Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	54.26	Buy
20-day SMA:	54.01	Buy
50-day SMA:	53.09	Buy
200-day SMA:	50.36	Buy
8-day EMA:	54.28	Buy
20-day EMA:	53.91	Buy
50-day EMA:	53.23	Buy
200-day EMA:	51.08	Buy

TVTX Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	35.7	Buy
20-day SMA:	35.23	Buy
50-day SMA:	33.43	Buy
200-day SMA:	22.2	Buy
8-day EMA:	28.52	Buy
20-day EMA:	16.32	Buy
50-day EMA:	7.67	Buy
200-day EMA:	2.09	Buy

Goldman Sachs MarketBeta Russell 1000 Value Eq ETF Earnings Growth & GVUS Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Travere Therapeutics, Inc. Earnings Growth & TVTX Earnings Dates

Analysts estimate an earnings increase this quarter of $0.54 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.58 per share, and an increase next year of $1.08 per share.

Goldman Sachs MarketBeta Russell 1000 Value Eq ETF Technical Analysis

	Dec 10	Dec 11	Dec 12	Dec 15	Dec 16	Dec 17	Dec 18	Dec 19	Dec 22	Dec 24
	Dec
	10	11	12	15	16	17	18	19	22	24
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Travere Therapeutics, Inc. Technical Analysis

	Dec 11	Dec 12	Dec 15	Dec 16	Dec 17	Dec 18	Dec 19	Dec 22	Dec 23	Dec 24
	Dec
	11	12	15	16	17	18	19	22	23	24
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):